Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Paracetamol poisoning

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    12 result(s) found for: Paracetamol poisoning. Displaying page 1 of 1.
    EudraCT Number: 2011-002213-12 Sponsor Protocol Number: I10 005 Start Date*: Information not available in EudraCT
    Sponsor Name:CHU de Limoges
    Full Title: Paracetamol and setrons : drug interactions in the management of pain after tonsillectomy in children
    Medical condition: Pain
    Disease: Version SOC Term Classification Code Term Level
    14.0 10022117 - Injury, poisoning and procedural complications 10049749 Post procedural pain LLT
    14.0 10022117 - Injury, poisoning and procedural complications 10064882 Procedural pain PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: View results
    EudraCT Number: 2009-017800-10 Sponsor Protocol Number: CZB/4/722 Start Date*: 2010-04-01
    Sponsor Name:NHS Lothian [...]
    1. NHS Lothian
    2. University of Edinburgh
    Full Title: Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning study (SNAP)
    Medical condition: Paracetamol overdose
    Disease: Version SOC Term Classification Code Term Level
    2.2 10033295 Overdose LLT
    2.2 10033297 accidental overdose LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-000246-21 Sponsor Protocol Number: PP100-001 Start Date*: 2017-04-25
    Sponsor Name:PledPharma AB
    Full Title: A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose
    Medical condition: The objective of this study is to develop a therapeutic regimen for paracetamol/acetaminophen overdose (POD) where a novel NAC 12hr regime is combined with a superoxide dismutase (SOD) mimetic, PP1...
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10033295 Overdose PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-000381-11 Sponsor Protocol Number: NL42823.018.13 Start Date*: 2013-05-17
    Sponsor Name:Academisch Medisch Centrum
    Full Title: Paracetamol or NSAID's in acute musculoskeletal syndromes
    Medical condition: acute musculoskeletal syndromes
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004865 10002182 Analgesia LLT
    17.1 100000004848 10033762 Paracetamol LLT
    17.1 10022117 - Injury, poisoning and procedural complications 10005942 Bone and joint injuries HLGT
    17.1 10022117 - Injury, poisoning and procedural complications 10028288 Muscle, tendon and ligament injuries HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2017-003875-77 Sponsor Protocol Number: 1870 Start Date*: 2018-01-24
    Sponsor Name:University Hospitals of North Midlands NHS Trust
    Full Title: A Randomised, Controlled Double Blinded Non-inferiority Trial of intravenous Morphine compared with intravenous Paracetamol for pain relief in patients presenting to the Emergency Department with S...
    Medical condition: Fractured Neck of Femur
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-000888-26 Sponsor Protocol Number: DEV 1477-2 DIC 05 Start Date*: 2005-11-07
    Sponsor Name:ratiopharm GmbH
    Full Title: Randomised, double-blind, multi-centre, placebo-controlled clinical dose finding study in four parallel groups comparing Diclofenac Gel 1 %, Diclofenac Gel 3 %, Diclofenac Gel 5 % and placebo Gel i...
    Medical condition: Male or female ambulant patients (age range 18-60 years) suffering from fresh impact injuries (traumatic blunt soft tissue injury/contusion). Time elapse between traumatic event and inclusion must ...
    Disease: Version SOC Term Classification Code Term Level
    10022117 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-004102-42 Sponsor Protocol Number: EP-DICLO/2G-01-2015 Start Date*: 2017-06-06
    Sponsor Name:Epifarma S.r.l.
    Full Title: Randomized, multi-center, double-blind, three-armed trial, to evaluate the non-inferiority, efficacy and safety of diclofenac2% gel (Test) versus the originator diclofenac2% gel chosen as Referenc...
    Medical condition: Acute traumatic events (injury/contusion) classified from mild to moderate pain at rest to the joints, muscles, tendons and ligaments
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10022117 Injury, poisoning and procedural complications SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing) LV (Completed) LT (Completed) HU (Ongoing) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-001779-29 Sponsor Protocol Number: EP-DICLO/G-01-2015 Start Date*: 2016-12-15
    Sponsor Name:Epifarma s.r.l.
    Full Title: Randomized, double-blind, parallel group, placebo-controlled, multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. (Test) versus the originato...
    Medical condition: Patients with acute painful and flogistic (inflammatory) disease due to acute traumatic events (injury/contusion) of joints, muscles, tendons and ligaments
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) DE (Completed) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002553-11 Sponsor Protocol Number: Highdoseinsulintherapy Start Date*: 2018-02-06
    Sponsor Name:Bispebjerg Hospital, University of Copenhagen
    Full Title: Cardiovascular effects of high dose insulin therapy. A multi-arm, randomized, participant-and-investigator-blinded, crossover study investigating glucagon's effects on heart rate, blood pressure, a...
    Medical condition: Insulin-induced increased heart rate, blood pressure and cardiac output
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004863 10035785 Poisoning by agents primarily affecting the cardiovascular system LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016466-82 Sponsor Protocol Number: cod16HS13 Start Date*: 2010-09-01
    Sponsor Name:CO.DON AG
    Full Title: Prospective, randomised, open label, multicentre Phase-III clinical trial to compare the efficacy and safety of the treatment with the autologous chondrocyte transplantation product co.don chondros...
    Medical condition: Cartilage defects of knee joints, osteochondral defects
    Disease: Version SOC Term Classification Code Term Level
    20.1 10022117 - Injury, poisoning and procedural complications 10007713 Cartilage tear in knee LLT
    20.0 100000004848 10007702 Cartilage biopsy LLT
    20.0 100000004859 10003423 Articular cartilage disorder LLT
    20.0 10042613 - Surgical and medical procedures 10052913 Cartilage operation PT
    20.0 10022117 - Injury, poisoning and procedural complications 10007705 Cartilage damage LLT
    20.0 100000004859 10007709 Cartilage disorders HLT
    20.0 10042613 - Surgical and medical procedures 10057104 Cartilage repair LLT
    20.1 10022117 - Injury, poisoning and procedural complications 10007710 Cartilage injury PT
    20.0 10042613 - Surgical and medical procedures 10064112 Cartilage graft PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2009-016816-20 Sponsor Protocol Number: cod16HS14 Start Date*: 2010-05-24
    Sponsor Name:co.don AG
    Full Title: Prospective, randomised, open label, multicentre Phase II clinical trial to investigate the efficacy and safety of the treatment of large defects (4-10 cm2) with 3 different doses of the autologous...
    Medical condition: Cartilage defects of knee joints, osteochondral defects
    Disease: Version SOC Term Classification Code Term Level
    18.0 10022117 - Injury, poisoning and procedural complications 10007713 Cartilage tear in knee LLT
    18.0 100000004848 10007702 Cartilage biopsy LLT
    18.0 100000004859 10003423 Articular cartilage disorder LLT
    18.0 10042613 - Surgical and medical procedures 10052913 Cartilage operation PT
    18.0 10022117 - Injury, poisoning and procedural complications 10007705 Cartilage damage LLT
    18.0 100000004859 10007709 Cartilage disorders HLT
    18.0 10042613 - Surgical and medical procedures 10057104 Cartilage repair LLT
    18.0 10022117 - Injury, poisoning and procedural complications 10007710 Cartilage injury PT
    18.0 10042613 - Surgical and medical procedures 10064112 Cartilage graft PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2017-003526-32 Sponsor Protocol Number: EQI7-16-02 Start Date*: 2018-08-14
    Sponsor Name:Fidia Farmaceutici S.p.A.
    Full Title: Randomised, double blind, parallel-groups, non-inferiority versus Flector® and superiority versus Placebo, Phase III clinical trial with Diclofenac Sodium 140 mg medicated plaster in patients with ...
    Medical condition: Patients with painful and phlogistic (inflammatory response) disease due to acute traumatic events (injury/contusion) of the limbs
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) HU (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 10 21:17:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA